Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (vol 24, 16, 2024)
Yükleniyor...
Tarih
2024
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
BMC
Erişim Hakkı
Attribution 4.0 International
info:eu-repo/semantics/openAccess
info:eu-repo/semantics/openAccess
Özet
[Abstract Not Available]
Açıklama
Anahtar Kelimeler
Metastatic Colorectal Cancer, Chemotherapy, Regorafenib, Third-Line Treatment
Kaynak
BMC Cancer
WoS Q Değeri
Q2
Scopus Q Değeri
Cilt
24
Sayı
1
Künye
Şenocak Taşçı, E., Oyan, B., Sönmez, Ö., Mutlu, A. U., Atçı, M. M., Sakin, A. ... Bozkurt, M. (2024). Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (vol 24, 16, 2024). BMC Cancer, 24(1). https://dx.doi.org/10.1186/s12885-024-11863-0
